The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

VIVUS Inc

Nasdaq: VVUS
Last

(U.S.) $1.09

Today's change+0.01 +0.93%
Updated February 17 4:00 PM EST. Delayed by at least 15 minutes.
 

VIVUS Inc

Nasdaq: VVUS
Last

(U.S.) $1.09

Today's change+0.01 +0.93%
Updated February 17 4:00 PM EST. Delayed by at least 15 minutes.

VIVUS Inc up (U.S.)$0.01

VIVUS Inc closed up Friday by (U.S.)$0.01 or 0.93% to (U.S.)$1.09. Over the last five days, shares have lost 1.80% and are down 5.22% for the last year to date. This security has underperformed the S&P 500 by 19.19% during the last year.

Key company metrics

  • Open(U.S.) $1.09
  • Previous close(U.S.) $1.08
  • High(U.S.) $1.12
  • Low(U.S.) $1.08
  • Bid / Ask(U.S.) $1.04 / (U.S.) $1.38
  • YTD % change-5.22%
  • Volume324,651
  • Average volume (10-day)422,097
  • Average volume (1-month)331,236
  • Average volume (3-month)443,862
  • 52-week range(U.S.) $0.93 to (U.S.) $1.85
  • Beta0.72
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.44
Updated February 17 4:00 PM EST. Delayed by at least 15 minutes.
S&P TSX0.16%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue13141515
Total other revenue--------
Total revenue13141515
Gross profit11111213
Total cost of revenue2343
Total operating expense14172020
Selling / general / administrative10141514
Research & development2113
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--0--0
Other operating expenses, total--------
Operating income-1-4-5-4
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-9-11-13-12
Income after tax-9-11-13-12
Income tax, total0000
Net income-9-11-13-12
Total adjustments to net income--------
Net income before extra. items-9-11-13-12
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-9-11-13-12
Inc. avail. to common incl. extra. items-9-11-13-12
Diluted net income-9-11-13-12
Dilution adjustment--0----
Diluted weighted average shares104104104104
Diluted EPS excluding extraordinary itemsvalue per share-0.09-0.11-0.12-0.12
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.09-0.11-0.12-0.12